Drug‐induced liver injury (DILI) ascribed to non‐steroidal anti‐inflammatory drugs (NSAIDs) in the USA—Update with genetic correlations

Documenti analoghi

• Liver Injury From Medications Used for Treating Inflammatory Bowel Disease: The Drug‐Induced Liver Injury Network Experience
  di: Harish Gopalakrishna, et al.
  Pubblicazione: (2026)
• Role of liver biopsy in the management of idiosyncratic DILI
  di: David E. Kleiner
  Pubblicazione: (2024)
• Drug‐Induced Liver Injury in Patients With Chronic Liver Disease
  di: Marwan Ghabril, et al.
  Pubblicazione: (2025)
• Update on heme biosynthesis, tissue‐specific regulation, heme transport, relation to iron metabolism and cellular energy
  di: Audrey Belot, et al.
  Pubblicazione: (2024)
• HLA ‐B*44 Alleles and HLA‐DQA1*03:01 as Genetic Risk Factors for Drug‐Induced Liver Injury due to Fluoroquinolones
  di: Paola Nicoletti, et al.
  Pubblicazione: (2026)